Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
CNY 3.77
(3.86%)
CNY 3.77
(3.86%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 1.19 Billion CNY | 11.26% |
| 2022 | 1.07 Billion CNY | 14.65% |
| 2021 | 937.14 Million CNY | 13.58% |
| 2020 | 825.07 Million CNY | 38.93% |
| 2019 | 593.87 Million CNY | 3.66% |
| 2018 | 572.88 Million CNY | 19.02% |
| 2017 | 481.34 Million CNY | 18.4% |
| 2016 | 406.55 Million CNY | -1.76% |
| 2015 | 413.85 Million CNY | 31.65% |
| 2014 | 314.36 Million CNY | 34.57% |
| 2013 | 233.6 Million CNY | 50.83% |
| 2012 | 154.87 Million CNY | -20.74% |
| 2011 | 195.39 Million CNY | 53.72% |
| 2010 | 127.11 Million CNY | 126.18% |
| 2009 | 56.2 Million CNY | 47.58% |
| 2008 | 38.08 Million CNY | 23.83% |
| 2007 | 30.75 Million CNY | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q1 | 1.13 Billion CNY | -5.43% |
| 2024 Q2 | 1.13 Billion CNY | 0.45% |
| 2024 Q3 | 1.08 Billion CNY | -4.12% |
| 2023 FY | 1.19 Billion CNY | 11.26% |
| 2023 Q1 | 1.27 Billion CNY | 19.13% |
| 2023 Q4 | 1.19 Billion CNY | -1.55% |
| 2023 Q2 | 1.13 Billion CNY | -11.37% |
| 2023 Q3 | 1.21 Billion CNY | 7.03% |
| 2022 Q3 | 1.13 Billion CNY | 3.77% |
| 2022 Q2 | 1.09 Billion CNY | 12.5% |
| 2022 Q1 | 975.69 Million CNY | 4.11% |
| 2022 FY | 1.07 Billion CNY | 14.65% |
| 2022 Q4 | 1.07 Billion CNY | -5.67% |
| 2021 Q1 | 948.26 Million CNY | 14.93% |
| 2021 Q3 | 938.29 Million CNY | 0.65% |
| 2021 FY | 937.14 Million CNY | 13.58% |
| 2021 Q4 | 937.14 Million CNY | -0.12% |
| 2021 Q2 | 932.28 Million CNY | -1.69% |
| 2020 Q3 | 771.82 Million CNY | 11.19% |
| 2020 Q1 | 631.95 Million CNY | 6.41% |
| 2020 FY | 825.07 Million CNY | 38.93% |
| 2020 Q2 | 694.16 Million CNY | 9.84% |
| 2020 Q4 | 825.07 Million CNY | 6.9% |
| 2019 Q1 | 550.07 Million CNY | -3.98% |
| 2019 FY | 593.87 Million CNY | 3.66% |
| 2019 Q4 | 593.87 Million CNY | 8.92% |
| 2019 Q3 | 545.23 Million CNY | -9.39% |
| 2019 Q2 | 601.71 Million CNY | 9.39% |
| 2018 Q1 | 530.6 Million CNY | 10.23% |
| 2018 Q3 | 501.28 Million CNY | -8.31% |
| 2018 FY | 572.88 Million CNY | 19.02% |
| 2018 Q2 | 546.69 Million CNY | 3.03% |
| 2018 Q4 | 572.88 Million CNY | 14.28% |
| 2017 Q3 | 533.93 Million CNY | 14.37% |
| 2017 Q2 | 466.83 Million CNY | -0.67% |
| 2017 Q1 | 469.98 Million CNY | 15.6% |
| 2017 Q4 | 481.34 Million CNY | -9.85% |
| 2017 FY | 481.34 Million CNY | 18.4% |
| 2016 FY | 406.55 Million CNY | -1.76% |
| 2016 Q3 | 408.45 Million CNY | 14.76% |
| 2016 Q4 | 406.55 Million CNY | -0.46% |
| 2016 Q1 | 375.18 Million CNY | -9.34% |
| 2016 Q2 | 355.92 Million CNY | -5.13% |
| 2015 Q2 | 327.46 Million CNY | -4.46% |
| 2015 Q4 | 413.85 Million CNY | 9.89% |
| 2015 FY | 413.85 Million CNY | 31.65% |
| 2015 Q1 | 342.74 Million CNY | 9.03% |
| 2015 Q3 | 376.62 Million CNY | 15.01% |
| 2014 Q1 | 247.61 Million CNY | 6.0% |
| 2014 FY | 314.36 Million CNY | 34.57% |
| 2014 Q4 | 314.36 Million CNY | 10.16% |
| 2014 Q3 | 285.37 Million CNY | 13.27% |
| 2014 Q2 | 251.93 Million CNY | 1.74% |
| 2013 Q2 | 216.62 Million CNY | 5.01% |
| 2013 Q4 | 233.6 Million CNY | 19.72% |
| 2013 Q3 | 195.12 Million CNY | -9.92% |
| 2013 Q1 | 206.28 Million CNY | 33.2% |
| 2013 FY | 233.6 Million CNY | 50.83% |
| 2012 Q3 | 190 Million CNY | 4.82% |
| 2012 FY | 154.87 Million CNY | -20.74% |
| 2012 Q1 | 247.59 Million CNY | 26.71% |
| 2012 Q2 | 181.25 Million CNY | -26.79% |
| 2012 Q4 | 154.87 Million CNY | -18.49% |
| 2011 Q3 | 185.93 Million CNY | 5.09% |
| 2011 FY | 195.39 Million CNY | 53.72% |
| 2011 Q1 | 158.05 Million CNY | 24.34% |
| 2011 Q2 | 176.93 Million CNY | 11.94% |
| 2011 Q4 | 195.39 Million CNY | 5.09% |
| 2010 Q2 | 112.67 Million CNY | 0.0% |
| 2010 Q4 | 127.11 Million CNY | 6.08% |
| 2010 FY | 127.11 Million CNY | 126.18% |
| 2010 Q3 | 119.82 Million CNY | 6.35% |
| 2009 Q4 | 56.2 Million CNY | 0.0% |
| 2009 FY | 56.2 Million CNY | 47.58% |
| 2008 FY | 38.08 Million CNY | 23.83% |
| 2007 FY | 30.75 Million CNY | 0.0% |